GENOMIC DNA AND MESSENGER-RNA EXPRESSION ALTERATIONS OF THE CDKN2B AND CDKN2 GENES IN ESOPHAGEAL SQUAMOUS CARCINOMA CELL-LINES

被引:17
作者
ZHOU, XL [1 ]
SUZUKI, H [1 ]
SHIMADA, Y [1 ]
IMAMURA, M [1 ]
YIN, J [1 ]
JIANG, HY [1 ]
TARMIN, L [1 ]
ABRAHAM, JM [1 ]
MELTZER, SJ [1 ]
机构
[1] UNIV MARYLAND,BALTIMORE,MD 21201
关键词
D O I
10.1002/gcc.2870130409
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The genes CDKN2B (MTS2) and CDKN2 (MTS1) encoding the proteins p15 and p16 are both located on chromosomal band 9p21, a locus at which frequent homozygous and heterozygous deletions occur in many primary human tumors, including esophageal carcinoma, CDKN2 and CDKN2B belong to a family of cyclin-dependent kinase 4 inhibitors (INK41) and control cell proliferation during the G1 phase of the cell cycle. Their inactivation may contribute to uncontrolled growth in human cancers. To investigate whether CDKN2B and CDKN2 are involved in esophageal tumorigenesis, we studied homozygous deletion, intragenic mutation, and messenger RNA (mRNA) expression of CDKN2 and CDKN2B in nine esophageal squamous cancer cell lines, Polymerase chain reaction (PCR) amplification revealed that five of the nine cell lines (55%) manifested homozygous deletions of CDKN2B, CDKN2, and/or flanking loci on chromosomal band 9p21. Reverse transcriptase-PCR (RT-PCR) was used to examine CDKN2 and CDKN2B mRNA in the nine cell lines. Lack of CDKN2 and CDKN2B mRNA correlated perfectly with homozygous deletion involving these genes. No subtle intragenic mutations of CDKN2B or CDKN2 were detected by DNA sequencing of their entire coding sequences in any cell lines lacking homozygous deletion. Two of the cell lines manifested homozygous deletions excluding CDKN2; one of these two deletions also excluded CDKN2B. These results suggest that inactivation of CDKN2B and CDKN2 may contribute to the malignant phenotype in esophageal cells and that homozygous deletion may be the predominant mechanism for inactivation of CDKN2B and CDKN2. Alternatively, a gene or genes adjacent to CDKN2B/CDKN2 may constitute the target(s) of deletion at this locus. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:285 / 290
页数:6
相关论文
共 29 条
[1]   ALLELOTYPE STUDY OF ESOPHAGEAL-CARCINOMA [J].
AOKI, T ;
MORI, T ;
DU, XQ ;
NISIHIRA, T ;
MATSUBARA, T ;
NAKAMURA, Y .
GENES CHROMOSOMES & CANCER, 1994, 10 (03) :177-182
[2]  
CAIRNS P, 1994, CANCER RES, V54, P1422
[3]   FREQUENT SOMATIC MUTATIONS AND HOMOZYGOUS DELETIONS OF THE P16 (MTS1) GENE IN PANCREATIC ADENOCARCINOMA [J].
CALDAS, C ;
HAHN, SA ;
DACOSTA, LT ;
REDSTON, MS ;
SCHUTTE, M ;
SEYMOUR, AB ;
WEINSTEIN, CL ;
HRUBAN, RH ;
YEO, CJ ;
KERN, SE .
NATURE GENETICS, 1994, 8 (01) :27-32
[4]  
GIANI C, 1994, CANCER RES, V54, P6338
[5]   P15(INK4B) IS A POTENTIAL EFFECTOR OF TGF-BETA-INDUCED CELL-CYCLE ARREST [J].
HANNON, GJ ;
BEACH, D .
NATURE, 1994, 371 (6494) :257-261
[6]  
HOLLAND EA, 1994, ONCOGENE, V9, P1361
[7]   FREQUENT MUTATION OF THE P53 GENE IN HUMAN ESOPHAGEAL CANCER [J].
HOLLSTEIN, MC ;
METCALF, RA ;
WELSH, JA ;
MONTESANO, R ;
HARRIS, CC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (24) :9958-9961
[8]  
HUANG DP, 1994, CANCER RES, V54, P4003
[9]  
HUANG Y, 1992, CANCER RES, V52, P6525
[10]  
JEN J, 1994, CANCER RES, V54, P6353